The Ankylosing Spondylitis Market, in terms of revenue, was valued at US$ 5.34 Bn in 2020 and is expected to reach US$ 6.84+ Bn by 2030.Ankylosing Spondylitis (AS) is a common chronic inflammatory rheumatic disease, which are seen in young adults, often in their late teens or early twenties. It can cause pain in lower back and neck. Over the time, AS can cause spine to become curved and rigid...